LYAR Suppresses Beta Interferon Induction by Targeting Phosphorylated Interferon Regulatory Factor 3

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Innate immune responses are crucial for host defense but require strict regulation.
• Mechanisms of negative regulation in innate immunity are not fully understood.
• The nucleolar protein LYAR was previously shown to promote viral replication.

Purpose of the Study:

• To investigate the role of LYAR in innate immune responses.
• To elucidate the mechanism by which LYAR modulates antiviral activity.
• To identify LYAR as a negative regulator of innate immunity.

Main Methods:

• Studied LYAR expression induction by beta interferon (IFN-β).
• Investigated the interaction between LYAR and phosphorylated IFN regulatory factor 3 (IRF3).
• Assessed the impact of LYAR on IRF3 DNA binding and transcriptional activity.
• Examined LYAR's effect on nuclear factor-κB (NF-κB) signaling.

Main Results:

• LYAR expression is induced by IFN-β during viral infections.
• LYAR interacts with phosphorylated IRF3, inhibiting its DNA binding.
• LYAR suppresses the transcription of IFN-β and IFN-stimulated genes (ISGs).
• LYAR inhibits NF-κB-mediated expression of proinflammatory cytokines.

Conclusions:

• LYAR acts as a negative regulator of innate immune responses.
• LYAR modulates IFN-β-mediated immunity by targeting phosphorylated IRF3.
• This finding provides insights into LYAR's role in viral replication and host defense.
• LYAR represents a novel target for controlling viral and inflammatory diseases.